Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637243 · ClinicalTrials.gov registry record
Outcomes From Treatment Liver and Bile Duct Diseases
A clinical trial, sponsored by Methodist Health System.
- Active
- Registry status
- 126
- Enrollment target
NCT04637243 is a clinical trial that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 126 participants.
The verdict
NCT04637243 is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 126 participants
- Enrollment target
Study Summary
It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. Our goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our multiple treatments of benign or malignant liver and bile duct diseases.
Interventions
- OTHER Treatment of Benign or Malignant Liver and Bile Duct Diseases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2023-03-09 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04637243
The ClinicalTrials.gov registry entry for NCT04637243 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment of Benign or Malignant Liver and Bile Duct Diseases is the first listed.
NCT04637243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04637243 about?
NCT04637243 is a clinical study titled "Outcomes From Treatment Liver and Bile Duct Diseases". It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving ...
What is the current status of trial NCT04637243?
This trial is currently active not recruiting. The enrollment target is 126 participants. The study started on 2023-03-09. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT04637243?
The interventions under investigation include: Treatment of Benign or Malignant Liver and Bile Duct Diseases (OTHER).
Who is sponsoring clinical trial NCT04637243?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.